Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Clinical trial NCT06847321 · RECRUITING

Trial details

NCT number: NCT06847321
Sponsor: Lighthouse Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Alzheimer Disease Due to P. Gingivalis

Start date: 2025-02-17
Primary completion: 2029-01-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.